EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

28 hedge funds and large institutions have $24.4M invested in Eagle Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+28
Holders Change %
–
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAM
Cormorant Asset Management
Massachusetts
+$5.1M
2
DM
Deerfield Management
New York
+$3.63M
3
PWAM
Park West Asset Management
California
+$2.67M
4
WSA
Wall Street Associates
California
+$2.55M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$2.27M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$8K +$8K +610 New
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$4K +$4K +300 New
Barclays
28
Barclays
United Kingdom
$1K +$1K +91 New
1
2